For a healthy premenopausal woman around age 30, free testosterone typically falls somewhere between about 1 and 6 pg/mL, though the exact range your lab report uses can vary depending on the assay method, your age, and where you are in your menstrual cycle. That range sounds simple enough, but free testosterone is one of the trickier hormones to measure accurately in women, and the number on your lab slip means less than you might expect without some context about what drives it up, pushes it down, and why “normal” is a moving target.
The Reference Range for Premenopausal Women
The most commonly cited population-based data on free testosterone in healthy cycling women comes from a study that carefully screened premenopausal volunteers to exclude conditions that would skew their hormone levels. For a 30-year-old woman, the estimated range spanning the 5th to 95th percentiles was 1.2 to 6.4 pg/mL, with calculated free testosterone in a slightly narrower band of 1.3 to 5.6 pg/mL.1PubMed. Testosterone reference ranges in normally cycling healthy premenopausal women A separate study of reproductive-age women found a mean free testosterone of about 1.4 pg/mL, which sits near the lower end of that range and likely reflects population and assay differences.2PubMed Central. Reference range of testosterone and dehydroepiandrosterone sulfate levels in women during reproductive age in the Iranian population
To put these numbers in perspective, women produce roughly a tenth to a twentieth as much testosterone as men, so the concentrations involved are very small. Free testosterone represents only about 1 to 3 percent of your total testosterone. The rest is bound to proteins in the blood, mainly sex hormone-binding globulin (SHBG) and albumin. Labs sometimes report total testosterone, free testosterone, or both, and the distinction matters because two women can have the same total testosterone yet very different free testosterone levels depending on how much SHBG they produce.
Why Free Testosterone Is Not the Same as Total Testosterone
Total testosterone includes all of it: the portion locked up on carrier proteins and the small sliver circulating unbound. Free testosterone is just the unbound fraction, and it is the portion that can enter cells and activate androgen receptors. There is also an “in between” fraction loosely bound to albumin, which some researchers consider biologically active because the binding is weak enough that tissues can strip it off. This is why some labs report “bioavailable testosterone,” which combines the free and albumin-bound portions. The ratio of total testosterone to SHBG has been proposed as a practical substitute for direct free testosterone measurement, and some evidence suggests it may even have better diagnostic accuracy in women being evaluated for excess androgen activity.3PubMed. Free testosterone and testosterone/SHBG index in hirsute women: a comparison of diagnostic accuracy
SHBG is the key player here. When SHBG goes up, it grabs more testosterone out of circulation, and your free testosterone drops even though your total testosterone might not change much. When SHBG goes down, more testosterone is left unbound and biologically active. This is why conditions and medications that shift SHBG can dramatically change the hormonal picture without affecting how much testosterone your body actually produces.
What Shifts SHBG and Reshapes Your Free Testosterone
Combined oral contraceptives are one of the biggest modifiers of free testosterone in premenopausal women. The estrogen component in the pill stimulates the liver to produce more SHBG, sometimes tripling it or more, which soaks up circulating testosterone. A systematic review and meta-analysis found that free testosterone dropped by an average of about 61 percent in women using combined oral contraceptives.4PubMed Central. The effect of combined oral contraception on testosterone levels in healthy women: a systematic review and meta-analysis The type of progestin in the pill matters too. Pills containing desogestrel raised SHBG concentrations and binding capacity far more than those containing levonorgestrel, though both types suppressed free testosterone by a similar amount.5American Journal of Obstetrics and Gynecology. Divergent effects of two low-dose oral contraceptives on sex hormone-binding globulin and free testosterone In practical terms, this means if you are on the pill and your lab draws show very low free testosterone, the pill is almost certainly responsible.
On the other side, insulin resistance and metabolic conditions push SHBG down. Lower SHBG means more of your testosterone floats free. This connection is well documented in polycystic ovary syndrome, where low SHBG amplifies the bioavailability of androgens and contributes to symptoms like acne, excess hair growth, and irregular cycles.6PubMed Central. Sex Hormone-Binding Globulin (SHBG) as an Early Biomarker and Therapeutic Target in Polycystic Ovary Syndrome Excess body fat, non-alcoholic fatty liver disease, and type 2 diabetes all tend to lower SHBG through overlapping metabolic pathways. So a woman with the same ovarian testosterone production as someone else can have a meaningfully higher free testosterone simply because her SHBG is suppressed by metabolic factors.
How Free Testosterone Changes Across the Menstrual Cycle
If you have had bloodwork drawn at different points in your cycle and noticed the numbers shifting, that is expected. Testosterone is not static throughout the month. A study tracking salivary testosterone across the menstrual cycle in nearly 300 women found that levels were significantly higher during the fertile window around ovulation compared to the luteal phase that follows it.7Hormones and Behavior. Salivary testosterone across the menstrual cycle Older research looking specifically at free testosterone in blood confirmed a more nuanced picture: total testosterone fell progressively across the cycle while the percentage that was free actually rose from the follicular into the luteal phase, with free testosterone dropping significantly only in the very late luteal phase just before menstruation.8PubMed. Free plasma testosterone levels during the normal menstrual cycle
The practical takeaway is that the timing of your blood draw matters. A free testosterone measured on cycle day 5 might look meaningfully different from one drawn at mid-cycle, and neither is “wrong.” Labs rarely specify cycle-day-specific reference ranges, so you and your clinician may need to factor in where you were in your cycle when interpreting a borderline result.
What Happens to Free Testosterone as You Age
Testosterone production in women declines gradually starting in the late reproductive years, well before menopause. A cross-sectional study of women at midlife found that median total testosterone dropped by about 25 percent between the early forties and late fifties, with the model predicting a low point around age 58 to 59 and a slight uptick after that.9eBioMedicine. Testosterone and pre-androgens by age and menopausal stage at midlife: findings from a cross-sectional study This is partly an ovarian story. As the ovaries wind down, they produce less testosterone and its precursors. But the adrenal glands also contribute to the decline, because the adrenal androgen DHEA-S, which the body converts into testosterone, falls steadily from early adulthood onward.
The interplay is not entirely straightforward, though. Research has shown that while the overall trajectory is downward, there can be a stage-specific bump in adrenal-derived androgens during the menopausal transition for many women, temporarily offsetting some of the ovarian decline.10PubMed Central. Adrenal Androgens and the Menopausal Transition After a surgical removal of both ovaries, the drop is much sharper and more abrupt, because the ovaries are responsible for a substantial chunk of testosterone production even in the perimenopausal years.
For postmenopausal women, free testosterone reference ranges are generally lower than those for premenopausal women, but many labs still use ranges derived from younger populations. This makes it genuinely difficult to tell when a postmenopausal woman’s testosterone is “too low,” because the ranges themselves are poorly validated for that life stage.
Why Free Testosterone Matters for Health
The clinical interest in free testosterone usually revolves around three areas: sexual desire and function, bone health, and the symptoms of androgen excess.
On the desire front, the connection between testosterone and libido in women is real but not as neat as the hormone-replacement marketing might suggest. Women who have low testosterone after menopause or oophorectomy often report reduced sexual desire, and a symptom-based clinical approach is increasingly recognized as more useful than relying on a particular blood level to diagnose the problem.11PubMed Central. Testosterone Therapy in Women: A Literature Review of Clinical Indications, Dosing, Routes of Administration, and Safety That is worth emphasizing: there is no single free testosterone number below which desire reliably vanishes or above which it reliably appears. Individual sensitivity varies, and symptoms matter more than the lab value in isolation.
For bone health, testosterone appears to play a supporting role alongside estrogen. In postmenopausal women, higher total testosterone has been associated with greater bone mineral density at the lumbar spine, with the relationship appearing strongest up to about 30 ng/dL of total testosterone.12PubMed Central. Association between Serum Total Testosterone Level and Bone Mineral Density in Middle-Aged Postmenopausal Women And in a small case series studying individuals receiving supraphysiologic testosterone therapy, bone density at the hip increased by nearly 8 percent over two years.13PubMed Central. Testosterone increases bone mineral density in female-to-male transsexuals: a case series of 15 subjects Researchers investigating selective androgen receptor modulators in animal models have found similar bone-protective effects, suggesting that androgen receptor activation itself, not just conversion to estrogen, contributes to skeletal maintenance.14PubMed Central. Selective Androgen Receptor Modulators in Women: What Do We Know, and What Is Still Missing
When Free Testosterone Is Too High
Elevated free testosterone in women is most commonly associated with PCOS, which affects roughly 6 to 12 percent of women of reproductive age depending on the diagnostic criteria used. Free testosterone tends to be a more sensitive marker of androgen excess than total testosterone in these cases, precisely because SHBG is often low in women with PCOS, amplifying the free fraction. Women with PCOS and depressive symptoms have been found to have significantly higher free testosterone levels compared to those without depression, hinting that the hormonal and psychological dimensions of the condition are intertwined.15Scientific Reports. Associations of free testosterone and gut Bifidobacterium with depressive symptoms among women with PCOS
Outside of PCOS, other causes of elevated testosterone include congenital adrenal hyperplasia, androgen-secreting tumors of the ovary or adrenal gland, and Cushing syndrome. Tumorous causes are rare but tend to produce very high testosterone levels and rapid onset of virilizing symptoms like voice deepening or clitoral enlargement. PCOS, by contrast, develops gradually and presents primarily with hirsutism, acne, and menstrual irregularity. Measuring testosterone is useful in sorting out the underlying cause, but interpreting the result requires care because the less accurate commercial assays can give misleading readings at the low concentrations found in women.16PubMed Central. Practical Approach to Hyperandrogenism in Women
The Measurement Problem
One reason this topic generates so much confusion is that measuring free testosterone accurately in women is technically difficult. The concentrations are very low, and the standard immunoassays many commercial labs use were originally designed for the much higher levels found in men. At female concentrations, these assays lose precision and can give results that are off by a wide margin. Newer methods using liquid chromatography with tandem mass spectrometry are more accurate but not yet widely available. One group using equilibrium dialysis with mass spectrometry found that in presumed-healthy women, the median free testosterone was about 8.6 picomoles per liter, while in women with suspected androgen excess, the median jumped to about 24 picomoles per liter. But even with this sensitive method, more than a third of the healthy women had free testosterone too low to reliably quantify.17Analytica Chimica Acta. Simultaneous quantitation of free testosterone and free thyroid hormones in human serum by equilibrium dialysis LC-MS/MS
This is an important reality check. If your lab’s assay cannot reliably measure levels in the range where healthy women actually sit, then a “low” result might simply be an artifact of the assay’s limits. Calculated free testosterone, where the lab measures total testosterone and SHBG and plugs them into a formula, can sidestep some of the assay-sensitivity issues, and it correlates fairly well with directly measured free testosterone in research settings. But it introduces its own assumptions about protein binding that may not hold in every individual.
Saliva Tests and At-Home Kits
Direct-to-consumer saliva kits that promise to reveal your testosterone status have surged in popularity, but the evidence for their reliability in women is not encouraging. Testosterone in saliva reflects the free fraction in blood, which sounds ideal, but the correlation between salivary testosterone and serum free testosterone in women is weaker than in men. One study using a highly accurate mass spectrometry method found only a modest correlation between salivary and serum free testosterone in female participants.18PubMed Central. Salivary Testosterone Measurement by Liquid Chromatography Tandem Mass Spectrometry in Adult Males and Females The concentrations in women’s saliva are so low that small sources of contamination, from gum bleeding to food residue, can throw off results. If you are looking for a clinically meaningful free testosterone measurement, a serum blood test through your physician’s lab remains a better bet, ideally drawn in the morning when testosterone peaks.
Tissue Sensitivity Adds Another Layer
Even if two women have the exact same free testosterone level, they may not experience the same androgenic effects. The androgen receptor gene, located on the X chromosome, contains a variable stretch of repeated DNA segments. The length of this repeat inversely correlates with how actively the receptor works: shorter repeats generally mean the receptor is more sensitive to testosterone, while longer repeats mean less sensitivity.19PubMed Central. Androgen receptor (AR) gene CAG trinucleotide repeat length associated with body composition measures in non-syndromic obese, non-obese and Prader-Willi syndrome individuals This genetic variation helps explain why some women develop hirsutism or acne at testosterone levels that are technically normal, while others with mildly elevated testosterone show no visible signs at all. It also complicates the idea that any single cutoff can separate “normal” from “abnormal.” A free testosterone of 5 pg/mL might be producing noticeable effects in a woman with short receptor repeats and barely registering in someone with long ones.
Free Testosterone and Cardiovascular Risk
A common concern, especially in discussions about testosterone therapy for postmenopausal women, is whether higher free testosterone raises cardiovascular risk. The evidence here is less alarming than some headlines suggest. A study of women with blood sugar abnormalities who were at high cardiovascular risk found that free testosterone concentration was not significantly associated with cardiovascular events or death from any cause.20PubMed Central. Testosterone and sex hormone-binding globulin in dysglycemic women at high cardiovascular risk Low SHBG, however, has been more consistently linked to metabolic and cardiovascular problems, and since low SHBG and high free testosterone tend to travel together, it can be difficult to disentangle which one is the actual driver. The research so far leans toward SHBG itself being the more informative marker for metabolic risk, with free testosterone being more of a bystander in that particular story.
Reading Your Lab Results
Lab reference ranges for free testosterone in women typically span something like 0.2 to 5 pg/mL or 0.3 to 6.4 pg/mL, but the numbers shift based on the assay and the reference population the lab used to set them. A few practical tips for making sense of your result:
- Check the units: pg/mL and pmol/L are both common. A value of 4.5 pg/mL is not the same as 4.5 pmol/L. Make sure you are comparing apples to apples if you are looking at reference data online.
- Note where you are in your cycle: A result drawn mid-cycle near ovulation will run higher than one from the late luteal phase, and most labs do not adjust for this.
- Factor in medications: If you are on a combined oral contraceptive, your free testosterone will be substantially suppressed, and a low value does not necessarily indicate a problem with your own testosterone production.
- Consider the assay method: If the report says “immunoassay” or “analog free testosterone,” the measurement is less precise at female levels. A calculated free testosterone based on total testosterone and SHBG may be more informative.
- Symptoms trump numbers: Clinicians increasingly rely on a symptom-based approach rather than rigid cutoffs, especially when evaluating low desire, fatigue, or mood changes in the perimenopausal and postmenopausal years.
This last point is worth sitting with. The field has moved away from the idea that free testosterone below some magic threshold means you need treatment, and away from the idea that free testosterone above some threshold means you have PCOS. Context, symptoms, and the trajectory of your levels over time all weigh more heavily than a single number drawn on a random Tuesday morning.